Comment on: Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?

The Original Article is available

A Reply to this article is available

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran A, et al. Levothyrox® new and old formulations: are they switchable for millions of patients? Clin Pharmacokinet. 2019. https://doi.org/10.1007/s40262-019-007747-3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Lindenblatt, et al. Solid pharmaceutical preparation containing levothyroxine. United States Patent Application Publication. Merck patent GMBH. US 2015/0231101 A1. 2015.

  3. 3.

    ANSM. Direction des contrôles. 12/09/2017. Note de synthèse 17-A-033.

  4. 4.

    Zamfirescu I, Carlson HE. Absorption of levothyroxine when coadministrated with various calcium formulations. Thyroid. 2011;21:483–6.

    CAS  Article  Google Scholar 

  5. 5.

    Poole RA, Kasper PT, Jiskoot W. Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations. J Pharm Sci. 2011;100:3018–22.

    CAS  Article  Google Scholar 

  6. 6.

    Chumsae C, Zhou LL, Shen Y, Wohlgemuth J, Fung E, Burton R, et al. Discovery of a chemical modification by citric acid in a recombinant monoclonal antibody. Anal Chem. 2014;86:8932–6.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Philippe Tréchot.

Ethics declarations

Funding

No external funds were used in the preparation of this letter.

Conflict of interest

Philippe Tréchot declares no potential conflicts of interest that might be relevant to the contents of this letter.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tréchot, P. Comment on: Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?. Clin Pharmacokinet 58, 977–978 (2019). https://doi.org/10.1007/s40262-019-00784-y

Download citation